| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c427c7eb9a5948fbbb2fc47288da7afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff2c8395c447d4d8519ce1b136c2c2a6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2012-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b77bf42d7fa726f6a11c0ac80da626e1 |
| publicationDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013302338-A1 |
| titleOfInvention |
Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody |
| abstract |
The present invention provides a novel isolated peptide segment which is a Dermatophagoid pteronyssinus (Der p1) antigen epitope, comprising one selected from the group consisting of the peptide segments having the amino acid sequences set forth in SEQ ID NO: 3 and SEQ ID NO: 4, and combination thereof. Also provided is an isolated antibody or antigen binding fragment thereof specific for a Dermatophagoid pteronyssinus (Der p1) antigen, which binds to the peptide segments having the amino acid sequences set forth in SEQ ID NO: 3 and SEQ ID NO: 4, and combination thereof. The present invention further provides a pharmaceutical composition for treating an IgE-mediated disease comprising a therapeutically effective amount of the antibody or antigen binding fragment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10059751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016079363-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015100360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020073645-A1 |
| priorityDate |
2012-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |